Through our steadfast dedication to collaborative research with the brightest minds, our technology participates in the most published studies and ongoing clinical trials on a global scale.
We are certified as a medical device manufacturer under MDSAP and ISO 13485.
Who we are
The technology of Vielight dates back to 1995 in the Silicon Valley – when the founders, Dr. Lew Lim and a group of engineers explored the potential of intranasal photobiomodulation. Intranasal photobiomodulation devices were commercially developed in 2003, which were later trademarked as “Vielight” when the company was incorporated in 2011.
Over the years, our focus shifted towards the development of unique photobiomodulation devices which enhance cognition and performance, among other things.
Today, our team has since evolved into a formidable team of engineers, scientists and business professionals dedicated to bringing the technology to as many people as possible.
Our dedication to research
Attaining our goal of helping people through photobiomodulation would not be possible without the right people. That is why Vielight have gathered many bright minds from a diverse range of scientific backgrounds to continuously improve the efficacy of brain and systemic photobiomodulation technology.
We appreciate and recognize our esteemed research collaborators:
• Reza Zomorrodi, PhD (Temerty Centre for Therapeutic Brain Intervention at CAMH, University of Toronto) • Margaret Naeser, PhD (Boston University School of Medicine, Boston VA Medical Center) • Paula Martin, PhD (Boston University School of Medicine, Boston VA Medical Center) • Michael Ho, PHD (Boston University School of Medicine, Boston VA Medical Center) • Peter Juni, MD, FESC (University of Toronto) • Alexander Lin, PhD (Harvard Medical School) • Corinne Fischer, MD (St Michael’s Hospital, University of Toronto) • Jack Tuszynski, PhD (University of Alberta) • Michael Staelens, PhD (Universty of Alberta) • Aarat Kalra, PhD (Princeton University) • David Tate, PhD (University of Utah) • Elisabeth Wilde, PhD (University of Utah) • Larry Carr, PhD (University of Utah) • Michael Larson, PhD (Brigham Young University) • Michael Hamblin, PhD (Harvard Medical School and University of Johannesburg) • Praveen Arany, PhD, DDS (University at Bufallo) • Jean Chen, PhD (Rotman Research Institute, University of Toronto) • Linda Chao, PhD (University of California San Francisco) • Julio C Rojas, MD, PhD (University of California San Francisco) • Vincent Clark, PhD (University of New Mexico) • Jay Sanguinetti, PhD (University of Arizona) • Richard Gevirtz, PhD (Alliant International University) • John Mitrofanis, PhD (University of Sydney) • Shima Fardad, PhD (University of Kansas)
Lew LimFounder & CEO
Dr Lew Lim is widely recognized as an expert on photobiomodulation (PBM), particularly in its application for brain functions and the effect on the immune system. He owns the largest number of worldwide issued and pending patents related to PBM as an individual.
Glynn JonesChief Financial Officer
Glynn is a Chartered Professional Accountant who trained at Ernst & Whinney and KPMG, and has many years experience in public practice and in senior financial positions at private and public companies, as well as in the University and non-profit sectors in British Columbia. He moved to Toronto and joined Vielight in 2013.
Peter AdamsVP, Business Development
Peter has worked in executive, consulting and management positions both internationally and in Canada, in large corporations and startups. He has also worked as a consultant at Fortune 500 companies. His current focus is on early-market development for Vielight Inc.
Vielight Research Division
Dr. Lew LimFounder & CEO
Dr Lew Lim, PhD, MBA, DNM, FCMA, CA(M), Grad Cert (Eng) is a Doctor of Natural Medicine, with graduate degrees, diplomas, certifications and professional credentials in engineering, neuroscience, business and accountancy. He obtained these from the University of California, Berkeley, Sheffield University, Duke University, Quantum University, Chartered Institute of Management Accountants (UK) and others.
He is widely recognized as an expert on photobiomodulation (PBM), particularly in its application for brain functions and the effect on the immune system. He owns the largest number of worldwide issued and pending patents related to PBM as an individual.
Dr. Nazanin HosseinkhahResearch Manager and Physicist
Nazanin has a MSc in Physics and a PhD in Medical Biophysics from University of Toronto, located at Sunnybrook Hospital.
Naz leads our covid-19 pivotal clinical trial and manages research projects in collaboration with the University of Alberta and Baycrest Hospital.
Given her background in biophysics, Naz’s passion aligns with Vielight’s goal of discovering how light energy could be used optimally to positively impact human physiology.
Dr. Genane LoheswaranResearch Manager and Neuroscientist
Genane holds a MSc in Neuroscience from McMaster University and a PhD in Pharmacology from the University of Toronto.
Gena manages Vielight’s research projects with various organizations for cognitive science, such as combining photobiomodulation with EEG.
Gena is passionate about neuroscience and a strong believer in the potential of photobiomodulation for improving mental acuity and brain health.
Dr. Mahroo KarimpoorResearch Scientist
Mahroo has a MSc in Tissue Engineering and Biomaterial Sciences and a PhD in Pharmaceutical and Biomaterial Science from University College London in the UK.
Mahroo is investigating the potential beneficial effects of photobiomodulation in elderly cognition and brain aging. She also researches the effects of photobiomodulation on neuro-oscillations.
Her interest in tissue engineering has lead her to find ways on how light energy could affect cellular mechanisms.
Dr. Janine LiburdClinical Trial Manager and Scientist
Janine holds a PhD in Biochemistry from Queens University, Ontario. Janine has been a part of Vielight since its founding.
Presently, she manages and handles Vielight’s pivotal Alzheimer’s disease clinical trial – including protocol planning, recruitment and operations.
Janine utilizes her decade-long experience in the field of photobiomodulation to help further discoveries.
Independent Research Collaborators
Dr. Elisabeth Wilde, PhDNeurologist and Health Scientist
Dr. Elisabeth Wilde is an Associate Professor in the Department of Neurology at the University of Utah. She also holds an appointment as a Health Research Scientist at the VA Salt Lake City Healthcare System.
She was a primary researcher in a groundbreaking n=49 TBI study, conducted at the University of Utah with ex-footballers, using the Vielight Neuro Gamma. The study is pending publication.
Dr. Jack TuszynskiComputational Biophysicist
Dr. Tuszynski is a Fellow of the National Institute for Nanotechnology of Canada. He is an Allard Chair and Professor in Experimental Oncology in the Department of Oncology at the University of Alberta’s Cross Cancer Institute and a Professor in the Department of Physics.
His research conducted with the Vielight Neuro Alpha provides a deeper level of understanding of the way living cells, cellular structures, and components such as microtubules respond to NIR photobiomodulation.
Dr. Margaret NaeserNeurologist and VA Health Scientist
Dr. Margaret Naeser is Research Professor of Neurology, Boston University School of Medicine and Research Linguist/Speech-Language Pathologist, V.A. Boston Healthcare System.
Dr. Naeser has published multiple TBI and CTE studies using Vielight Neuro technology on US Army Veterans.
Dr. Reza ZomorrodiNeuroscientist and EEG Researcher
Dr. Reza Zomorrodi has a PhD in Nuclear Physics and a PhD in Computational Neuroscience from Université Laval in Quebec.
Dr. Zomorrodi was the first in the world to publish a scientific paper showing the neuromodulatory effects of NIR light energy on the brain. The study used the Vielight Neuro Gamma. To date, the Vielight Neuro Gamma is the only commercially available brain photobiomodulation device to demonstrate neuromodulatory effects in a peer-reviewed published study in a high level journal.
Dr. Linda ChaoNeuroscientist and Radiologist
Linda Chao, PhD, is a Professor in the Department of Radiology and Biomedical Imaging and in the Department of Psychiatry at the University of California, San Francisco. Dr. Chao obtained her BS in Biological Science from the University of California, Davis in 1991, and she completed her PhD studies in Neuroscience from UCD in 1996. For the past 11-years, she has served as leader for the Psychiatry Block.
Dr. Chao was the first to successfully combine fMRI imaging with brain photobiomodulation research to evidence neurophysiological changes in Alzheimer’s patients. She used the Vielight Neuro in her studies.
Dr. David TateNeuropsychologist
Dr. David Tate is a clinical neuropsychologist trained at Brigham Young University and Brown Medical School. He is heavily involved in medical imaging research used to examine a number of developmental, clinical, and medical disorders including traumatic brain injury.
Dr. Tate was a primary researcher in a groundbreaking n=49 TBI study, conducted at the University of Utah with ex-footballers, using the Vielight Neuro Gamma. The study is pending publication.
Dr. Neda Rashidi-Ranjbar, MDMedical Monitor
Dr. Neda Rashidi-Ranjbar a Clinician Scientist holding both an MD and a PhD, currently serves as a postdoctoral fellow at St. Michael’s Hospital. She earned her doctoral degree in medical science from the University of Toronto. At present, Dr. Nana is at the forefront of pioneering research focused on the application of photobiomodulation (PBM) for the treatment of Mild Cognitive Impairment (MCI).
Dr. Larry CarrResearcher
Dr. Larry Carr is a former BYU graduate and BYU Hall of Fame Football player. He received a Ph.D. from BYU in exercise physiology and taught at the university level until CTE-like symptoms forced him to step down.
Dr. Carr was enrolled in a CTE-study by Dr. Naeser and was inspired by the Vielight Neuro’s ability to greatly improve his CTE-symptoms, bringing him back to baseline. As such, he now leads several research initiatives for brain photobiomodulation, TBI and CTE at the U of Utah.
Dr. Jean ChenNeuroscientist and EEG Researcher
Dr. Chen received her MSc (2004) in Electrical Engineering from the University of Calgary, and her PhD (2009) in Biomedical Engineering from McGill University. She completed her postdoctoral work on multimodal MRI of brain aging at Harvard Medical School (2011). She is a Senior Scientist at the Rotman Research Institute and Tier II Canada Research Chair in Neuroimaging of Aging.
Dr. Chen is conducting fMRI-based studies with Vielight technology on the brain, to help discover optimal brain photobiomodulation parameters.
Dr. Michael HamblinResearcher
Prof M.R. Hamblin (Ph.D.) was the Principal Investigator at the Wellman Center for Photomedicine at Massachusetts General Hospital, an Associate Professor of Dermatology at Harvard Medical School and is a member of the affiliated faculty of the Harvard-MIT Division of Health Science and Technology.
Dr. Hamblin co-authored the world’s first published study suggesting efficacy for brain photobiomodulation for Alzheimer’s Disease. The study featured Vielight Neuro technology.
Dr. Javier PeñaResearcher
Dr. Javier Peña currently works at the Faculty of Psychology and Education, University of Deusto. Javier does research in Neuropsychology, Abnormal Psychology, Clinical Psychology and creativity. Their current project is ‘Neurocrea Project’.
Dr. Peña co-authored the first published study linking brain photobiomodulation to improved creativity. The study featured Vielight Neuro technology.
Marketing and Analytics Division
Dominic Jake King LimOperations Director
Dominic graduated with a BSc. in Mathematics from Wilfrid Laurier University.
He is involved in company operations, spanning from facilitating operational plans, strategic initiatives, part-time web development and social media engagement.
Austin GaneshProduct Coordinator
Austin has a HBSc from the University of Toronto and an MMgt from the Schulich School of Business.
Austin’s responsibilities as the Product Coordinator at Vielight include facilitating operational plans, providing backend support, and supporting business development.
Mingyang ChenQuality and Product Technologist
Mingyang is a Quality and Product Engineer at Vielight. He holds a BEng and a MEng in Materials Engineering from McGill University.
Mingyang conducted research at the McGill Additive Manufacturing Laboratory applying Laser Powder Bed Fusion technology on aircraft components. He has expertise in engineering design, materials characterization, and Lean Six Sigma.
Peter KusiakSports Manager and Regulatory Associate
Peter has a HBSc from University of Toronto, and Graduate Certificate in A.I. from Durham College.
Peter is involved in sports market development and works with product and quality teams to address regulatory projects.
Liyao JiManager, Quality and Regulatory Affairs
Liyao is the Manager, Quality and Regulatory Affairs at Vielight. She takes the lead in quality assurance and regulatory projects. She has a MSc in Biotechnology from McGill University.
Liyao is a certified Regulatory Affairs professional and holds the Regulatory Affairs Certificate (RAC-Device) issued by Regulatory Affairs Professional Society (RAPS).
Amy ZhangQuality System and Projects Engineer
Amy holds a Master’s degree in Mechanical Engineering from the University of Saskatchewan, Canada.
She is a licensed professional engineer with over a decade of experience in mechanical engineering. Her expertise lies in project coordination and management, regulatory documentation, mechanical engineering design, mechanical property testing, and stress/fatigue analysis through FEA.
Rico PetriniSports Performance Consultant
Rico Petrini holds a specialty dual major from Oregon State University in Business Administration and Communications. While at Oregon State, Rico also was a 4-year starter on the Football team, an ALL-League selection at Linebacker, and Team MVP.
Rico’s primary passion is an interest in neuro-tech studies, research, and performance. His responsibilities at Vielight include matching our extensive line of products with the best solution to maximize potential in sports, cognitive support, or optimal systemic wellness & recovery.
As a small but dynamic company, we’re constantly innovating.
Interested in keeping up to date? Sign up for our newsletter.
Brighten your brain.
Subscribe to our newsletter.
Main line: 1-877-355-8012 Neuro Pro: 1-855-777-3830 Research Inquiries: 1-888-730-3805